Clinical study of fluconazole-injectable and -granules in pediatric patients

Seki, H.; Seno, A.; Sakazume, S.; Shinoda, K.; Shintani, N.; Wada, T.; Wada, H.; Koizumi, S.; Taniguchi, N.; Horita, S.

Japanese Journal of Antibiotics 47(3): 289-295

1994


ISSN/ISBN: 0368-2781
PMID: 8182900
Document Number: 435297
In this study, we have investigated the clinical effectiveness of fluconazole (FLCZ) given intravenously or orally to pediatric patients with systemic fungal infections. FLCZ was administered intravenously to two patients with acute leukemia (multiple hepatosplenic candidiasis and aspergillosis) and orally to two mycosis complicated with neuroblastoma and aplastic anemia, respectively. Clinical efficacies were excellent and no side effects were observed in any patients. Pharmacokinetic analysis in 6 neonates revealed that the plasma half-life is 37 apprx 41 hours after administration of single dose of intravenous infusion of 3 mg/kg of FLCZ.

Document emailed within 1 workday
Secure & encrypted payments